Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susann-Cathrin Olthof

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Diagnostics (Basel, Switzerland)|July 29, 2023
Influence of [<sup>18</sup>F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry StudySebastian Werner, Julia Sekler, Brigitte Gückel, et al.
European Radiology|December 6, 2022
Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?Daniel Wessling, Simon Männlin, Ricarda Schwarz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2018
Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in GermanyChristina Pfannenberg, Brigitte Gueckel, Lisa Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
Impact of <sup>18</sup>F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysisAndrea Forschner, Susann-Cathrin Olthof, Brigitte Gückel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Intention-to-Treat Analysis of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After SurgeryJohannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Diagnostics (Basel, Switzerland)|July 29, 2023
Influence of [<sup>18</sup>F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry StudySebastian Werner, Julia Sekler, Brigitte Gückel, et al.
European Radiology|December 6, 2022
Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?Daniel Wessling, Simon Männlin, Ricarda Schwarz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2018
Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in GermanyChristina Pfannenberg, Brigitte Gueckel, Lisa Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
Impact of <sup>18</sup>F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysisAndrea Forschner, Susann-Cathrin Olthof, Brigitte Gückel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Intention-to-Treat Analysis of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After SurgeryJohannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, et al.
Pageof 2